📰 Leukemia News
Page 173 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
March 12, 2022
The disease was once a virtual death sentence for children. Today, his aggressive treatments mean that almost everyone survives it.
March 12, 2022
Covered up for decades, the partial meltdown of a nuclear reactor near Los Angeles in 1959 has had devastating consequences for families living nearby.
March 10, 2022
- TIBSOVO is an inhibitor of the mutated isocitrate dehydrogenase-1(IDH1) enzyme - TIBSOVO is the first IDH1 mutation specific targeted therapy submitted in Europe - The submission
March 10, 2022
Gregory Berk, M.D., the Companys President of R&D and Chief Medical Officer noted, "This pre-clinical evidence suggests, despite the difference in circulating immune cells of Stage IVB NSCLC patients, a mesothelin-targeted TriKE can work alongside current standard of care and provide benefit even in the hypoxic environment of a solid
March 10, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 9, 2022
A family of six who moved from El Cajon to Phoenix just before the coronavirus pandemic hit are relying on funds generously donated to their GoFundMe as they...
March 9, 2022
Disruptions to the lung microbiome are linked to a number of respiratory conditions in both children and adults.
March 9, 2022
Disruptions to the lung microbiome are linked to a number of respiratory conditions in both children and adults.
March 8, 2022
Black and Hispanic people with acute myeloid leukemia in greater Chicago were more likely to die from the disease than their non-Hispanic white counterparts, with a 59% and 25% greater risk, respectively, according to a new study led by University of Illinois Chicago researchers.
March 7, 2022
Scientists from Vanderbilt-Ingram Cancer Center (VICC) collaborated with researchers from New York to determine that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease, according to a study published March 7 in Nature Medicine.